IceCure's (ICCM) ProSense Breast Cancer Study Meets Endpoint - Zacks Investment Research
IceCure Medical Ltd. Ordinary Shares · Now $0.20
-3.9% in 7d after detection
Post-detection moves
1h
—
1d
+3.3%
3d
+3.1%
7d
-3.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS